Martin Duerden
- Economics and Econometrics top 5%
- Geriatrics and Gerontology top 2%
- General Health Professions top 10%
- Pediatrics, Perinatology and Child Health
- Pulmonary and Respiratory Medicine
- Co-authors
- Dyfrig HughesRupert PaynePolly DuncanDavid PriceStewart W MercerCarol SinnottColin BradleyMolly Byrne
- Topics
- Pharmaceutical Practices and Patient Outcomes (10 papers)Health Systems, Economic Evaluations, Quality of Life (9 papers)Pharmaceutical Economics and Policy (8 papers)
- Partner nations
- United KingdomGermanySouth Africa
In The Last Decade
Martin Duerden
29 papers receiving 495 citations
Peers
Comparison fields: 5 of 89
- Economics and Econometrics 197
- Geriatrics and Gerontology 136
- General Health Professions 106
- Pediatrics, Perinatology and Child Health 89
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Martin Duerden
This map shows the geographic impact of Martin Duerden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Duerden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Duerden more than expected).
Fields of papers citing papers by Martin Duerden
This network shows the impact of papers produced by Martin Duerden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Duerden. The network helps show where Martin Duerden may publish in the future.
Co-authorship network of co-authors of Martin Duerden
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Duerden. A scholar is included among the top collaborators of Martin Duerden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Duerden. Martin Duerden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 15 | |
| 4 | 0 | |
| 5 | 18 | |
| 6 | 69 | |
| 7 | 87 | |
| 8 | 39 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 34 | |
| 12 | 3 | |
| 13 | 112 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | A budget impact model for a drug in heart failure: eplerenone | 1 |
| 17 | 1 | |
| 18 | 11 | |
| 19 | 14 | |
| 20 | 12 |
About Martin Duerden
Martin Duerden is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Family Practice, having authored 32 papers that have together received 518 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (8 papers). The work is most often cited by research in Geriatrics and Gerontology (136 citations), Applied Microbiology and Biotechnology (56 citations) and Family Practice (47 citations). Martin Duerden has collaborated with scholars based in United Kingdom, Germany and South Africa. Frequent co-authors include Dyfrig Hughes, Rupert Payne, Polly Duncan, David Price, Stewart W Mercer, Carol Sinnott, Colin Bradley, Molly Byrne, Norma O’Flynn and Nadeem Qureshi. Their work appears in journals such as British Journal of Clinical Pharmacology, Implementation Science and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.